As per the top European Union's official, two of prominent vaccine candidates for the ongoing pandemic-Moderna and Pfizer could receive conditional market authorisation by the second half of December 2020. The European Commission has sealed the deal with multiple pharma companies including BioNTech and Pfizer, to buy millions of doses of Covid-19 vaccine.
Moderna vaccine partner Lonza Group is focussing on ensuring a smooth rollout of the safe and effective Covid-19 vaccine. Majority of the production of Moderna's vaccine drug substance is running via Lonza. In an initial analysis, its Covid-19 vaccine was found to be 94.5 per cent effective.